HEADER MEMBRANE PROTEIN 20-NOV-20 7B0R TITLE IN MESO STRUCTURE OF THE MEMBRANE INTEGRAL LIPOPROTEIN INTRAMOLECULAR TITLE 2 TRANSACYLASE LIT FROM BACILLUS CEREUS WITH H85R MUTATION COMPND MOL_ID: 1; COMPND 2 MOLECULE: HYPOTHETICAL MEMBRANE SPANNING PROTEIN; COMPND 3 CHAIN: A; COMPND 4 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: BACILLUS CEREUS (STRAIN ATCC 14579 / DSM 31 / SOURCE 3 JCM 2152 / NBRC 15305 / NCIMB 9373 / NRRL B-3711); SOURCE 4 ORGANISM_TAXID: 226900; SOURCE 5 STRAIN: ATCC 14579 / DSM 31 / JCM 2152 / NBRC 15305 / NCIMB 9373 / SOURCE 6 NRRL B-3711; SOURCE 7 GENE: BC_1526; SOURCE 8 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 9 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS LIPOPROTEIN, LIPID CUBIC PHASE, LIT, MEMBRANE PROTEIN, TRANSACYLASE EXPDTA X-RAY DIFFRACTION AUTHOR C.-Y.HUANG,S.OLATUNJI,V.OLIERIC,M.CAFFREY REVDAT 3 31-JAN-24 7B0R 1 REMARK REVDAT 2 28-JUL-21 7B0R 1 JRNL REVDAT 1 26-MAY-21 7B0R 0 JRNL AUTH S.OLATUNJI,K.BOWEN,C.Y.HUANG,D.WEICHERT,W.SINGH, JRNL AUTH 2 I.G.TIKHONOVA,E.M.SCANLAN,V.OLIERIC,M.CAFFREY JRNL TITL STRUCTURAL BASIS OF THE MEMBRANE INTRAMOLECULAR TRANSACYLASE JRNL TITL 2 REACTION RESPONSIBLE FOR LYSO-FORM LIPOPROTEIN SYNTHESIS. JRNL REF NAT COMMUN V. 12 4254 2021 JRNL REFN ESSN 2041-1723 JRNL PMID 34253723 JRNL DOI 10.1038/S41467-021-24475-0 REMARK 2 REMARK 2 RESOLUTION. 2.20 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX 1.17.1-3660 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.20 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 40.80 REMARK 3 MIN(FOBS/SIGMA_FOBS) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 100.0 REMARK 3 NUMBER OF REFLECTIONS : 14504 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : NULL REMARK 3 R VALUE (WORKING SET) : 0.230 REMARK 3 FREE R VALUE : 0.280 REMARK 3 FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 FREE R VALUE TEST SET COUNT : NULL REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : NULL REMARK 3 SOLVENT RADIUS : NULL REMARK 3 SHRINKAGE RADIUS : NULL REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : NULL REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : NULL REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 55.07 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : NULL NULL REMARK 3 ANGLE : NULL NULL REMARK 3 CHIRALITY : NULL NULL REMARK 3 PLANARITY : NULL NULL REMARK 3 DIHEDRAL : NULL NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 7B0R COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 20-NOV-20. REMARK 100 THE DEPOSITION ID IS D_1292112426. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 15-APR-20 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 6.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : DIAMOND REMARK 200 BEAMLINE : I24 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.96862 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS3 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : XSCALE REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 14531 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.200 REMARK 200 RESOLUTION RANGE LOW (A) : 40.800 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 92.6 REMARK 200 DATA REDUNDANCY : 6.480 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 10.4600 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.20 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.33 REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 1.230 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: 7B0O REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 55.53 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.77 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 100 MM MES/NAOH, PH 6.0, 125-200 MM M REMARK 280 LITHIUM CITRATE TRIBASIC TETRAHYDRATE, AND 36-44 %(V/V) PEG 400, REMARK 280 LIPIDIC CUBIC PHASE, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 1 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y,-Z REMARK 290 3555 X+1/2,Y+1/2,Z REMARK 290 4555 -X+1/2,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 3 1.000000 0.000000 0.000000 57.23600 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 22.43550 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 57.23600 REMARK 290 SMTRY2 4 0.000000 1.000000 0.000000 22.43550 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A -18 REMARK 465 HIS A -17 REMARK 465 HIS A -16 REMARK 465 HIS A -15 REMARK 465 HIS A -14 REMARK 465 HIS A -13 REMARK 465 HIS A -12 REMARK 465 SER A -11 REMARK 465 LYS A 214 REMARK 465 LYS A 215 REMARK 465 PHE A 216 REMARK 465 SER A 217 REMARK 465 ALA A 218 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 LYS A 118 CG CD CE NZ REMARK 470 GLU A 146 CG CD OE1 OE2 REMARK 470 LYS A 147 CG CD CE NZ REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 MET A 211 0.52 -69.98 REMARK 500 REMARK 500 REMARK: NULL REMARK 610 REMARK 610 MISSING HETEROATOM REMARK 610 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 610 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 610 I=INSERTION CODE): REMARK 610 M RES C SSEQI REMARK 610 PE5 A 305 REMARK 610 PG5 A 310 REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue GOL A 301 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue GOL A 302 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue OLC A 303 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue OLC A 304 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue PE5 A 305 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue GOL A 306 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC7 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue OLC A 307 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC8 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue OLC A 308 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC9 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue CIT A 309 REMARK 800 REMARK 800 SITE_IDENTIFIER: AD1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue PG5 A 310 DBREF 7B0R A 1 218 UNP Q813T3 Q813T3_BACCR 1 218 SEQADV 7B0R MET A -18 UNP Q813T3 INITIATING METHIONINE SEQADV 7B0R HIS A -17 UNP Q813T3 EXPRESSION TAG SEQADV 7B0R HIS A -16 UNP Q813T3 EXPRESSION TAG SEQADV 7B0R HIS A -15 UNP Q813T3 EXPRESSION TAG SEQADV 7B0R HIS A -14 UNP Q813T3 EXPRESSION TAG SEQADV 7B0R HIS A -13 UNP Q813T3 EXPRESSION TAG SEQADV 7B0R HIS A -12 UNP Q813T3 EXPRESSION TAG SEQADV 7B0R SER A -11 UNP Q813T3 EXPRESSION TAG SEQADV 7B0R SER A -10 UNP Q813T3 EXPRESSION TAG SEQADV 7B0R GLY A -9 UNP Q813T3 EXPRESSION TAG SEQADV 7B0R ARG A -8 UNP Q813T3 EXPRESSION TAG SEQADV 7B0R GLU A -7 UNP Q813T3 EXPRESSION TAG SEQADV 7B0R ASN A -6 UNP Q813T3 EXPRESSION TAG SEQADV 7B0R LEU A -5 UNP Q813T3 EXPRESSION TAG SEQADV 7B0R TYR A -4 UNP Q813T3 EXPRESSION TAG SEQADV 7B0R PHE A -3 UNP Q813T3 EXPRESSION TAG SEQADV 7B0R GLN A -2 UNP Q813T3 EXPRESSION TAG SEQADV 7B0R GLY A -1 UNP Q813T3 EXPRESSION TAG SEQADV 7B0R HIS A 0 UNP Q813T3 EXPRESSION TAG SEQADV 7B0R ARG A 85 UNP Q813T3 HIS 85 ENGINEERED MUTATION SEQRES 1 A 237 MET HIS HIS HIS HIS HIS HIS SER SER GLY ARG GLU ASN SEQRES 2 A 237 LEU TYR PHE GLN GLY HIS MET ASP ARG LEU ILE THR LEU SEQRES 3 A 237 VAL VAL SER TYR SER ILE ALA PHE SER ILE PHE ALA LEU SEQRES 4 A 237 ALA THR MET ALA VAL VAL TYR GLY LYS TRP LEU TYR TYR SEQRES 5 A 237 PHE GLU ILE ASP PHE LEU ASN ILE PRO ASP LEU ALA ASP SEQRES 6 A 237 MET THR LYS ASP GLU ILE LYS ARG ASN TYR ASP VAL LEU SEQRES 7 A 237 ILE THR TYR LEU SER PRO PHE TYR ASP GLY ALA LEU HIS SEQRES 8 A 237 LEU PRO THR LEU ASP MET SER THR ASN GLY ARG ILE ARG SEQRES 9 A 237 PHE VAL ASP VAL LYS ASN ILE LEU VAL LYS ILE GLN TYR SEQRES 10 A 237 VAL MET TYR ALA THR ILE MET ILE ALA VAL ILE GLY GLY SEQRES 11 A 237 ILE TYR LEU LEU LYS LYS LYS ASN GLU LYS PHE LEU LEU SEQRES 12 A 237 HIS GLY SER ILE LEU THR ILE ILE PHE PRO ILE ALA LEU SEQRES 13 A 237 MET LEU PRO ILE ALA ILE ASN PHE GLU LYS SER PHE VAL SEQRES 14 A 237 LEU PHE HIS LYS LEU LEU PHE SER ASN ASP TYR TRP VAL SEQRES 15 A 237 PHE ASP PRO GLU LYS ASP PRO ILE ILE LEU MET LEU PRO SEQRES 16 A 237 GLU GLU PHE PHE MET HIS ALA ALA CYS ALA ILE LEU LEU SEQRES 17 A 237 PHE ILE LEU GLY GLY SER ILE LEU CYS TYR SER LEU TYR SEQRES 18 A 237 ARG TYR LEU VAL LYS LYS LYS ARG MET SER GLN LYS LYS SEQRES 19 A 237 PHE SER ALA HET GOL A 301 6 HET GOL A 302 6 HET OLC A 303 25 HET OLC A 304 25 HET PE5 A 305 20 HET GOL A 306 6 HET OLC A 307 25 HET OLC A 308 25 HET CIT A 309 13 HET PG5 A 310 10 HETNAM GOL GLYCEROL HETNAM OLC (2R)-2,3-DIHYDROXYPROPYL (9Z)-OCTADEC-9-ENOATE HETNAM PE5 3,6,9,12,15,18,21,24-OCTAOXAHEXACOSAN-1-OL HETNAM CIT CITRIC ACID HETNAM PG5 1-METHOXY-2-[2-(2-METHOXY-ETHOXY]-ETHANE HETSYN GOL GLYCERIN; PROPANE-1,2,3-TRIOL HETSYN OLC 1-OLEOYL-R-GLYCEROL HETSYN PE5 2-(2-{2-[2-(2-{2-[2-(2-ETHOXY-ETHOXY)-ETHOXY]-ETHOXY}- HETSYN 2 PE5 ETHOXY)-ETHOXY]-ETHOXY}-ETHOXY)-ETHANOL; POLYETHYLENE HETSYN 3 PE5 GLYCOL PEG400 FORMUL 2 GOL 3(C3 H8 O3) FORMUL 4 OLC 4(C21 H40 O4) FORMUL 6 PE5 C18 H38 O9 FORMUL 10 CIT C6 H8 O7 FORMUL 11 PG5 C8 H18 O4 FORMUL 12 HOH *43(H2 O) HELIX 1 AA1 SER A -10 TYR A 27 1 38 HELIX 2 AA2 LYS A 29 LEU A 39 1 11 HELIX 3 AA3 ASN A 40 ASP A 46 1 7 HELIX 4 AA4 THR A 48 LEU A 63 1 16 HELIX 5 AA5 SER A 79 LYS A 117 1 39 HELIX 6 AA6 GLU A 120 LEU A 137 1 18 HELIX 7 AA7 MET A 138 ASN A 144 1 7 HELIX 8 AA8 ASN A 144 PHE A 157 1 14 HELIX 9 AA9 ASP A 169 LEU A 175 5 7 HELIX 10 AB1 PRO A 176 MET A 211 1 36 SITE 1 AC1 4 ALA A 24 GLY A 28 LEU A 31 GOL A 302 SITE 1 AC2 4 GLY A 28 LYS A 29 TRP A 30 GOL A 301 SITE 1 AC3 6 ARG A 85 PHE A 86 PHE A 164 PHE A 179 SITE 2 AC3 6 PHE A 180 OLC A 304 SITE 1 AC4 6 ILE A 96 MET A 138 PHE A 180 ALA A 184 SITE 2 AC4 6 LEU A 188 OLC A 303 SITE 1 AC5 6 PRO A 74 THR A 75 LEU A 76 ASP A 77 SITE 2 AC5 6 ASN A 91 LYS A 95 SITE 1 AC6 5 LYS A 53 ARG A 54 ALA A 70 ARG A 83 SITE 2 AC6 5 HOH A 428 SITE 1 AC7 7 LEU A 20 TYR A 27 PRO A 65 GLN A 97 SITE 2 AC7 7 MET A 100 TYR A 101 OLC A 308 SITE 1 AC8 3 PHE A 190 GLY A 194 OLC A 307 SITE 1 AC9 8 ARG A -8 SER A -10 GLY A -9 ASP A 43 SITE 2 AC9 8 ASP A 46 MET A 47 ASP A 68 HOH A 404 SITE 1 AD1 3 ARG A 3 TYR A 11 ILE A 143 CRYST1 114.472 44.871 69.543 90.00 121.06 90.00 C 1 2 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.008736 0.000000 0.005261 0.00000 SCALE2 0.000000 0.022286 0.000000 0.00000 SCALE3 0.000000 0.000000 0.016786 0.00000